The FDA issued updates on December 13 regarding drugs that are currently in shortage:
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated – Currently in Shortage)
- Lithium Carbonate Capsules (New – Discontinuation)
- Montelukast Sodium Chewable Tablet (New – Discontinuation)
- Norethindrone and Ethinyl Estradiol Tablets (New – Discontinuation)
- Sertraline Hydrochloride Tablets (New – Discontinuation)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
